Skip to main content
Fig. 2 | BMC Medicine

Fig. 2

From: Antidepressant use and cognitive decline in patients with dementia: a national cohort study

Fig. 2

Estimated MMSE trajectories between use of antidepressants and non-use by antidepressant class and individual drugsa. Abbreviations: SveDem, the Swedish Registry for Cognitive/Dementia Disorders; CIs, confidence intervals; MMSE, Mini-Mental State Examination; SSRIs, selective serotonin reuptake inhibitors; SNRIs, serotonin and norepinephrine reuptake inhibitors; TCAs, Tricyclic antidepressants; Others, other antidepressants. a, Estimated MMSE trajectories from mixed model, adjusted for age, sex, calendar year of diagnosis, the type of dementia, MMSE score at diagnosis, coresident status, care unit, depression, fracture, Charlson Comorbidity Index score, medications (angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), β-blocking agents, calcium channel blockers, nonsteroidal anti-inflammatory drugs, diuretics, lipid-modifying agents, antiplatelets, antipsychotics, anxiolytics, and hypnotics)

Back to article page